Sponsor

University of Adelaide

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Adelaide appears in 27 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials27
Recruiting shown4
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

27 shown
Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 DiabetesNCT06942195 · lead sponsor · 2025-05-22
RECRUITING
Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy)NCT04869098 · lead sponsor · 2021-04-27
RECRUITING
Calories or Time Restriction to Alter Biomarkers of Aging and DiabetesNCT05769335 · lead sponsor · 2023-03-15
COMPLETED
AVocAdo Extract to Improve gLycemia in Individuals With Obesity (AVAIL)NCT04763473 · lead sponsor · 2021-03-09
COMPLETED
What Or When to Eat to Reduce the Risk of Type 2 Diabetes (WOW)NCT04762251 · lead sponsor · 2021-02-17
COMPLETED
The Impact of Glucotoxicity on Gastric Emptying in Chinese Patients With Newly Diagnosed Type 2 DiabetesNCT05284344 · lead sponsor · 2021-01-24
COMPLETED
Quality of Life After Bariatric SurgeryNCT04524429 · lead sponsor · 2020-06-23
UNKNOWN
Daily vs Intermittent Restriction of Energy: Controlled Trial to Reduce Diabetes Risk (DIRECT)NCT03689608 · lead sponsor · 2018-09-26
COMPLETED
Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric AirNCT03138746 · lead sponsor · 2018-08-13
COMPLETED
Time RestrIcted Feeding For Improving Diabetes Risk (TRIFFID)NCT03590158 · lead sponsor · 2018-07-17
COMPLETED
Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?NCT03278236 · lead sponsor · 2017-09-21
TERMINATED
Intermittent Fasting for Metabolic Health, Does Meal Timing Matter?NCT02633722 · lead sponsor · 2016-01-01
COMPLETED
Does Hyperbaric Oxygen Therapy Lead to a Sustained Increase in Insulin Sensitivity?NCT02136615 · lead sponsor · 2014-07-01
COMPLETED
Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session.NCT02009813 · lead sponsor · 2013-03-01
COMPLETED
Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF)NCT01522898 · lead sponsor · 2013-03-01
COMPLETED
Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI EvaluationNCT02164435 · lead sponsor · 2013-01-01
UNKNOWN
Hyperbaric Oxygen Treatment Ameliorates Insulin ResistanceNCT01361971 · lead sponsor · 2011-04-01
COMPLETED
Metabolic Phenotyping of Individuals Born Following Assisted Reproduction TechniquesNCT01230632 · lead sponsor · 2010-09-01
COMPLETED
Transition of Single Surgeon Bariatric Service to an Interdisciplinary Multiple Surgeon ModelNCT04431583 · lead sponsor · 2008-01-01
COMPLETED
Weight Loss Effects on Heart and Blood Vessel Function in ObesityNCT00782262 · lead sponsor · 2005-04-01
UNKNOWN
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)NCT05114096 · collaborator · 2023-07-20
RECRUITING
The Glaucoma Nicotinamide TrialNCT05275738 · collaborator · 2022-05-18
RECRUITING
Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.NCT06888687 · collaborator · 2025-05-12
ACTIVE_NOT_RECRUITING
An Observational Study of Distress, Immune Function, and Pain in HIV.NCT04757987 · collaborator · 2021-02-11
COMPLETED
Gastric Emptying - Implications for the Pathogenesis of Type 2 DiabetesNCT03864562 · collaborator · 2019-03-01
COMPLETED
Towards a Functional Cure for HBV - The COMMIT Cohort StudyNCT03645044 · collaborator · 2018-05-24
ACTIVE_NOT_RECRUITING
Methods Study to Characterize Early Indicators of Weight Loss in PeopleNCT00383253 · collaborator · 2006-10-01
COMPLETED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Adelaide as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor20
collaborator7
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.